Roundhill GLP-1 & Weight Loss ETF Rating $22.77 +0.77 (+3.50%) As of 04/17/2025 02:32 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Roundhill GLP-1 & Weight Loss ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.OZEM Aggregate RatingModerate Buy 2.77Holdings in OZEM have an aggregate rating of Moderate Buy based on 227 analyst ratings issued in the past year covering 18 companies (66.6% of the portfolio).OZEM Aggregate Price Target$22.77High Prediction$22.77Average Prediction$22.77Low Prediction$22.77Holdings in OZEM have an aggregate price target of $22.77 and a range of $22.77 to $22.77 covering 18 companies (66.6% of the portfolio).OZEM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy8 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Roundhill GLP-1 & Weight Loss ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 18 OZEM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings17.67%LLYEli Lilly and Company$841.70+14.5%4.7938 of 5 stars2.89$1,012.00 20.2%19News CoverageGap UpHigh Trading Volume12.68%NVONovo Nordisk A/S$57.99-7.8%4.6167 of 5 stars2.40$135.00 132.8%10Analyst DowngradeGap DownHigh Trading Volume5.16%AZNAstraZeneca$67.54+0.7%3.5109 of 5 stars3.09$86.80 28.5%11Analyst ForecastShort Interest ↓Positive News4.69%AMGNAmgen$277.29-1.9%4.6044 of 5 stars2.48$314.91 13.6%23Analyst DowngradeAnalyst Revision3.69%PFEPfizer$22.13+0.4%4.9986 of 5 stars2.59$31.07 40.4%172.65%GILDGilead Sciences$104.49-0.4%4.5305 of 5 stars2.72$105.12 0.6%29Upcoming EarningsInsider TradeNews CoveragePositive News2.42%REGNRegeneron Pharmaceuticals$563.16+2.5%4.8424 of 5 stars2.77$963.56 71.1%26Analyst ForecastNews CoveragePositive News2.40%TAKTakeda Pharmaceutical$14.69+0.2%2.6985 of 5 stars3.001News Coverage2.30%VKTXViking Therapeutics$23.94+1.4%4.2747 of 5 stars2.92$89.75 274.9%13Upcoming EarningsAnalyst ForecastOptions VolumeNews CoveragePositive NewsGap Up2.20%ALTAltimmune$4.56+3.5%2.795 of 5 stars2.89$20.83 357.4%9Positive News2.07%GPCRStructure Therapeutics$21.76+17.4%2.5734 of 5 stars3.00$81.29 273.6%8News CoverageGap UpHigh Trading Volume1.76%RYTMRhythm Pharmaceuticals$61.74+0.7%3.9501 of 5 stars3.00$74.92 21.4%13Analyst RevisionPositive News1.61%SRRKScholar Rock$30.71+3.2%3.8936 of 5 stars3.00$42.67 39.0%6News CoveragePositive News1.55%OPKOPKO Health$1.424.1082 of 5 stars3.00$2.75 93.7%3Options Volume1.32%CORTCorcept Therapeutics$62.24-3.7%4.4127 of 5 stars3.00$143.25 130.2%5Positive News1.16%BHVNBiohaven$20.41+9.2%3.6485 of 5 stars3.07$62.77 207.6%15Analyst RevisionGap Up1.08%TERNTerns Pharmaceuticals$2.41+7.4%4.1469 of 5 stars2.60$18.38 664.0%5News CoveragePositive NewsGap Up0.17%KROSKeros Therapeutics$14.07+4.0%3.6874 of 5 stars2.57$40.33 186.7%14 This page (NASDAQ:OZEM) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roundhill GLP-1 & Weight Loss ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Roundhill GLP-1 & Weight Loss ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OZEM Stock Free OZEM Stock Alerts